348 related articles for article (PubMed ID: 31014518)
1. Systemic therapy in cervical cancer: 30 years in review.
Liontos M; Kyriazoglou A; Dimitriadis I; Dimopoulos MA; Bamias A
Crit Rev Oncol Hematol; 2019 May; 137():9-17. PubMed ID: 31014518
[TBL] [Abstract][Full Text] [Related]
2. Advances in immunotherapy for cervical cancer.
Wendel Naumann R; Leath CA
Curr Opin Oncol; 2020 Sep; 32(5):481-487. PubMed ID: 32740092
[TBL] [Abstract][Full Text] [Related]
3. Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy.
Kozaki M; Sakuma S; Kudaka W; Kinjyo Y; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nakamoto T; Wakayama A; Ooyama T; Aoki Y
Arch Gynecol Obstet; 2017 Nov; 296(5):997-1003. PubMed ID: 28884382
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemotherapy in Locally Advanced Cervical Cancer After Treatment with Concomitant Chemoradiotherapy--Room for Improvement?
Jelavić TB; Miše BP; Strikic A; Ban M; Vrdoljak E
Anticancer Res; 2015 Jul; 35(7):4161-5. PubMed ID: 26124372
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer.
McLachlan J; Boussios S; Okines A; Glaessgen D; Bodlar S; Kalaitzaki R; Taylor A; Lalondrelle S; Gore M; Kaye S; Banerjee S
Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):153-160. PubMed ID: 27838135
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for recurrent and metastatic cervical cancer.
Tao X; Hu W; Ramirez PT; Kavanagh JJ
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Kurtz JE; D'Hondt V; Lécuru F; Lhommé C
Bull Cancer; 2017 May; 104 Suppl 1():S39-S42. PubMed ID: 28625314
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in advanced and recurrent cervical cancer. A review.
Park RC; Thigpen JT
Cancer; 1993 Feb; 71(4 Suppl):1446-50. PubMed ID: 8431878
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for recurrent cervical cancer.
Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
[TBL] [Abstract][Full Text] [Related]
10. Changing paradigms in the systemic treatment of advanced cervical cancer.
Pfaendler KS; Tewari KS
Am J Obstet Gynecol; 2016 Jan; 214(1):22-30. PubMed ID: 26212178
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of chemoradiotherapy for advanced cervical cancer].
Kaneyasu Y; Okawa MK; Okawa T
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2084-91. PubMed ID: 9388517
[TBL] [Abstract][Full Text] [Related]
12. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of recurrent cervical cancer].
Sekiba K; Hayase R
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1839-42. PubMed ID: 2393303
[TBL] [Abstract][Full Text] [Related]
14. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix.
Omura GA
J Natl Cancer Inst Monogr; 1996; (21):123-6. PubMed ID: 9023841
[TBL] [Abstract][Full Text] [Related]
16. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
Tewari KS; Monk BJ
Semin Oncol; 2009 Apr; 36(2):170-80. PubMed ID: 19332251
[TBL] [Abstract][Full Text] [Related]
17. Integration of bevacizumab with chemotherapy doublets for advanced cervical cancer.
Krill LS; Tewari KS
Expert Opin Pharmacother; 2015 Apr; 16(5):675-83. PubMed ID: 25643984
[TBL] [Abstract][Full Text] [Related]
18. Management of recurrent cervical cancer: a review of the literature.
Peiretti M; Zapardiel I; Zanagnolo V; Landoni F; Morrow CP; Maggioni A
Surg Oncol; 2012 Jun; 21(2):e59-66. PubMed ID: 22244884
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
20. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
